We are pleased to inform you about the future IMI topics as just received from the IMI Office.

These topics are:

• Development and validation of technology enabled, quantitative and sensitive measures of functional decline in people with early stage Alzheimer’s disease (RADAR-AD)
• Fairification of IMI and EFPIA data
• Development of sensitive and validated clinical endpoints in primary Sjögren’s syndrome (PSS)
• European screening centre: unique library for attractive biology
• Exploitation of IMI project results (updated version of February 2017)